Bio-Rad Laboratories Revenue 2010-2023 | BIO
- Bio-Rad Laboratories revenue for the quarter ending December 31, 2023 was $0.681B, a 6.72% decline year-over-year.
- Bio-Rad Laboratories revenue for the twelve months ending December 31, 2023 was $2.671B, a 4.67% decline year-over-year.
- Bio-Rad Laboratories annual revenue for 2023 was $2.671B, a 4.67% decline from 2022.
- Bio-Rad Laboratories annual revenue for 2022 was $2.802B, a 4.12% decline from 2021.
- Bio-Rad Laboratories annual revenue for 2021 was $2.923B, a 14.81% increase from 2020.
Bio-Rad Laboratories Annual Revenue (Millions of US $) |
|
---|---|
2023 | $2,671 |
2022 | $2,802 |
2021 | $2,923 |
2020 | $2,546 |
2019 | $2,312 |
2018 | $2,289 |
2017 | $2,160 |
2016 | $2,068 |
2015 | $2,019 |
2014 | $2,175 |
2013 | $2,133 |
2012 | $2,069 |
2011 | $2,074 |
2010 | $1,927 |
2009 | $1,784 |
Bio-Rad Laboratories Quarterly Revenue (Millions of US $) |
|
---|---|
2023-12-31 | $681 |
2023-09-30 | $632 |
2023-06-30 | $681 |
2023-03-31 | $677 |
2022-12-31 | $730 |
2022-09-30 | $681 |
2022-06-30 | $691 |
2022-03-31 | $700 |
2021-12-31 | $733 |
2021-09-30 | $747 |
2021-06-30 | $716 |
2021-03-31 | $727 |
2020-12-31 | $790 |
2020-09-30 | $647 |
2020-06-30 | $537 |
2020-03-31 | $572 |
2019-12-31 | $624 |
2019-09-30 | $561 |
2019-06-30 | $573 |
2019-03-31 | $554 |
2018-12-31 | $617 |
2018-09-30 | $545 |
2018-06-30 | $576 |
2018-03-31 | $552 |
2017-12-31 | $621 |
2017-09-30 | $534 |
2017-06-30 | $505 |
2017-03-31 | $500 |
2016-12-31 | $571 |
2016-09-30 | $509 |
2016-06-30 | $517 |
2016-03-31 | $471 |
2015-12-31 | $571 |
2015-09-30 | $470 |
2015-06-30 | $506 |
2015-03-31 | $473 |
2014-12-31 | $598 |
2014-09-30 | $531 |
2014-06-30 | $537 |
2014-03-31 | $509 |
2013-12-31 | $603 |
2013-09-30 | $505 |
2013-06-30 | $525 |
2013-03-31 | $500 |
2012-12-31 | $574 |
2012-09-30 | $499 |
2012-06-30 | $510 |
2012-03-31 | $486 |
2011-12-31 | $550 |
2011-09-30 | $517 |
2011-06-30 | $522 |
2011-03-31 | $485 |
2010-12-31 | $534 |
2010-09-30 | $472 |
2010-06-30 | $468 |
2010-03-31 | $454 |
2009-12-31 | $495 |
2009-09-30 | $461 |
2009-06-30 | $427 |
2009-03-31 | $401 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $9.711B | $2.671B |
Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $193.473B | 25.11 |
Stryker (SYK) | United States | $133.123B | 33.06 |
Medtronic (MDT) | Ireland | $111.139B | 15.73 |
EssilorLuxottica (ESLOY) | France | $102.775B | 0.00 |
Boston Scientific (BSX) | United States | $99.865B | 33.14 |
Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
Haleon (HLN) | United Kingdom | $38.831B | 30.04 |
ResMed (RMD) | United States | $28.562B | 28.56 |
Terumo (TRUMY) | Japan | $27.589B | 38.84 |
Zimmer Biomet Holdings (ZBH) | United States | $26.224B | 16.91 |
Baxter (BAX) | United States | $21.095B | 15.39 |
Koninklijke Philips (PHG) | Netherlands | $18.610B | 14.84 |
Insulet (PODD) | United States | $11.574B | 60.85 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.401B | 0.00 |
Demant (WILYY) | Denmark | $11.148B | 0.00 |
BellRing Brands (BRBR) | United States | $7.779B | 41.82 |
Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
GN Store Nord (GNNDY) | Denmark | $4.150B | 26.87 |
Haemonetics (HAE) | United States | $4.146B | 21.20 |
Lantheus Holdings (LNTH) | United States | $4.027B | 10.40 |
Prestige Consumer Healthcare (PBH) | United States | $3.575B | 16.90 |
Envista Holdings (NVST) | United States | $3.561B | 13.57 |
Neogen (NEOG) | United States | $3.248B | 31.25 |
QuidelOrtho (QDEL) | United States | $3.142B | 11.41 |
Green Thumb Industries (GTBIF) | United States | $2.981B | 94.47 |
ICU Medical (ICUI) | United States | $2.433B | 18.32 |
TG Therapeutics (TGTX) | United States | $2.384B | 772.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.097B | 0.00 |
Owens & Minor (OMI) | United States | $2.036B | 19.54 |
Verano Holdings (VRNOF) | United States | $1.879B | 0.00 |
InMode (INMD) | Israel | $1.736B | 8.99 |
National Vision Holdings (EYE) | United States | $1.710B | 53.24 |
Agios Pharmaceuticals (AGIO) | United States | $1.633B | 0.00 |
AdaptHealth (AHCO) | United States | $1.499B | 11.28 |
LeMaitre Vascular (LMAT) | United States | $1.470B | 48.81 |
AtriCure (ATRC) | United States | $1.407B | 0.00 |
Warby Parker (WRBY) | United States | $1.254B | 0.00 |
MacroGenics (MGNX) | United States | $0.888B | 0.00 |
Quanterix (QTRX) | United States | $0.834B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.820B | 0.00 |
Evolus (EOLS) | United States | $0.803B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.706B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.702B | 15.18 |
Canopy Growth (CGC) | Canada | $0.659B | 0.00 |
Valneva SE (VALN) | France | $0.543B | 0.00 |
Jin Medical (ZJYL) | China | $0.527B | 0.00 |
PetIQ (PETQ) | United States | $0.524B | 19.55 |
TerrAscend (TSNDF) | Canada | $0.521B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.520B | 11.26 |
OraSure Technologies (OSUR) | United States | $0.465B | 7.70 |
Biote (BTMD) | United States | $0.440B | 4.18 |
ZimVie (ZIMV) | United States | $0.431B | 26.53 |
Surmodics (SRDX) | United States | $0.402B | 43.40 |
Zynex (ZYXI) | United States | $0.397B | 45.74 |
Viemed Healthcare (VMD) | United States | $0.352B | 34.96 |
Sanara MedTech (SMTI) | United States | $0.317B | 0.00 |
Cerus (CERS) | United States | $0.315B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.253B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.247B | 14.91 |
TriSalus Life Sciences (TLSI) | United States | $0.245B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.230B | 0.00 |
Omeros (OMER) | United States | $0.218B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.199B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.182B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.173B | 0.00 |
High Tide (HITI) | Canada | $0.155B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.143B | 0.00 |
Fonar (FONR) | United States | $0.137B | 11.80 |
InterCure (INCR) | Israel | $0.116B | 19.61 |
Societal CDMO (SCTL) | United States | $0.115B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.110B | 0.00 |
FitLife Brands (FTLF) | United States | $0.107B | 20.86 |
Safety Shot (SHOT) | United States | $0.100B | 0.00 |
MariMed (MRMD) | United States | $0.098B | 0.00 |
Brainsway (BWAY) | Israel | $0.091B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
Chimerix (CMRX) | United States | $0.088B | 0.00 |
Veru (VERU) | United States | $0.084B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.083B | 45.50 |
Zevia PBC (ZVIA) | United States | $0.070B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.27 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.047B | 0.00 |
Bright Green (BGXX) | United States | $0.045B | 0.00 |
Apyx Medical (APYX) | United States | $0.044B | 0.00 |
Modular Medical (MODD) | United States | $0.042B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.035B | 13.52 |
FSD PHARMA (HUGE) | Canada | $0.028B | 0.00 |
Agape ATP (ATPC) | $0.027B | 0.00 | |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
ProSomnus (OSA) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |